Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reimbursement models to tackle market failures for antimicrobials: Approaches taken in France, Germany, Sweden, the United Kingdom, and the United States
Dzintars Gotham, Lorenzo Moja, Maarten van der Heijden, et al.
Health Policy (2020) Vol. 125, Iss. 3, pp. 296-306
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed
Mark S. Butler, Valeria Gigante, Hatim Sati, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 3
Open Access | Times Cited: 193
Review of Antimicrobial Nanocoatings in Medicine and Dentistry: Mechanisms of Action, Biocompatibility Performance, Safety, and Benefits Compared to Antibiotics
James A. Butler, Richard D. Handy, Mathew Upton, et al.
ACS Nano (2023) Vol. 17, Iss. 8, pp. 7064-7092
Open Access | Times Cited: 95
Global Strategies to Combat Antimicrobial Resistance: A One Health Perspective
Steward Mudenda, Billy Chabalenge, Victor Daka, et al.
Pharmacology & Pharmacy (2023) Vol. 14, Iss. 08, pp. 271-328
Open Access | Times Cited: 48
WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections
Lorenzo Moja, Veronica Zanichelli, Dominik Mertz, et al.
Clinical Microbiology and Infection (2024) Vol. 30, pp. S1-S51
Open Access | Times Cited: 34
Shortage of essential antimicrobials: a major challenge to global health security
Nusrat Shafiq, Avaneesh Kumar Pandey, Samir Malhotra, et al.
BMJ Global Health (2021) Vol. 6, Iss. 11, pp. e006961-e006961
Open Access | Times Cited: 69
Advancing global antibiotic research, development and access
Laura J. V. Piddock, Yewande Alimi, James L. Anderson, et al.
Nature Medicine (2024) Vol. 30, Iss. 9, pp. 2432-2443
Closed Access | Times Cited: 12
Assessing Clinician Utilization of Next-Generation Antibiotics Against Resistant Gram-Negative Infections in U.S. Hospitals
Jeffrey R. Strich, Ahmed Ullah Mishuk, Guoqing Diao, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 5, pp. 559-572
Closed Access | Times Cited: 9
Tracking progress on antimicrobial resistance by the quadripartite country self-assessment survey (TrACSS) in G7 countries, 2017–2023: opportunities and gaps
Michela Sabbatucci, Diane Ashiru‐Oredope, Laura Barbier, et al.
Pharmacological Research (2024) Vol. 204, pp. 107188-107188
Open Access | Times Cited: 9
There is no market for new antibiotics: this allows an open approach to research and development
Dana M. Klug, Fahima I. M. Idiris, Mark A. T. Blaskovich, et al.
Wellcome Open Research (2021) Vol. 6, pp. 146-146
Open Access | Times Cited: 48
Can the UK ‘Netflix’ Payment Model Boost the Antibacterial Pipeline?
C.T. Leonard, Nick Crabb, David M. Glover, et al.
Applied Health Economics and Health Policy (2023) Vol. 21, Iss. 3, pp. 365-372
Open Access | Times Cited: 17
Lipopolysaccharide as an antibiotic target
Akshay Sabnis, Andrew M. Edwards
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1870, Iss. 7, pp. 119507-119507
Open Access | Times Cited: 16
Tackling the threat of antimicrobial resistance in neonates and children: outcomes from the first WHO-convened Paediatric Drug Optimisation exercise for antibiotics
Alasdair Bamford, Tiziana Masini, Phoebe Williams, et al.
The Lancet Child & Adolescent Health (2024) Vol. 8, Iss. 6, pp. 456-466
Closed Access | Times Cited: 6
The role of vaccines in combating antimicrobial resistance (AMR) bacteria
Saad Alghamdi
Saudi Journal of Biological Sciences (2021) Vol. 28, Iss. 12, pp. 7505-7510
Open Access | Times Cited: 33
Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use
Laurence S. J. Roope, Liz Morrell, James Buchanan, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 4
Reforming the innovation system to deliver affordable medicines: a conceptual framework of pharmaceutical innovation as a complex adaptive system (forest) and theory of change
Suerie Moon, Adrián Alonso Ruiz, Marcela Vieira, et al.
Journal of Pharmaceutical Policy and Practice (2025) Vol. 18, Iss. 1
Open Access
Sustainable Pharmacy‒a guiding principle
Kenneth W. Witte, Michael Müller
Sustainable Chemistry and Pharmacy (2025) Vol. 44, pp. 101897-101897
Open Access
Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?
Abigail Colson, Alec Morton, Christine Årdal, et al.
Value in Health (2021) Vol. 24, Iss. 12, pp. 1828-1834
Open Access | Times Cited: 27
Estimating The Appropriate Size Of Global Pull Incentives For Antibacterial Medicines
Kevin Outterson
Health Affairs (2021) Vol. 40, Iss. 11, pp. 1758-1765
Closed Access | Times Cited: 24
Strategies to improve antibiotic access and a way forward for lower middle-income countries
Himika Wasan, K.H. Reeta, Yogendra Kumar Gupta
Journal of Antimicrobial Chemotherapy (2023) Vol. 79, Iss. 1, pp. 1-10
Open Access | Times Cited: 9
Implementing an EU pull incentive for antimicrobial innovation and access: blueprint for action
Michael Anderson, Adrian Towse, Kevin Outterson, et al.
The Lancet Microbe (2024), pp. 100886-100886
Open Access | Times Cited: 3
Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis: a commentary on the proposed EU pharma regulation
Astrid Berner-Rodoreda, Frank Cobelens, Anne–Mieke Vandamme, et al.
BMJ Global Health (2024) Vol. 9, Iss. 2, pp. e014605-e014605
Open Access | Times Cited: 2
Improving equitable access for effective antibacterials: an ecosystem approach
Jennifer Cohn, Manica Balasegaram, Hema Srinivasan, et al.
Clinical Microbiology and Infection (2024)
Open Access | Times Cited: 2
Addressing Challenges in Antibiotic Access: Barriers, Implications and Strategies for Solution
Ritika Kondel Bhandari, Avaneesh Kumar Pandey, Samir Malhotra, et al.
Pharmaceutical Medicine (2024)
Closed Access | Times Cited: 2
Global access to existing and future antimicrobials and diagnostics: antimicrobial subscription and pooled procurement
Daniel Berman, Sujith J Chandy, Oliver Cansdell, et al.
The Lancet Global Health (2021) Vol. 10, Iss. 2, pp. e293-e297
Open Access | Times Cited: 16
Bacterial envelope stress responses: Essential adaptors and attractive targets
Timothy H. S. Cho, Kat Pick, Tracy Raivio
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2022) Vol. 1870, Iss. 2, pp. 119387-119387
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top